Inspire Medical Systems, Inc. Announces Chair Marilyn Carlson Nelson to Retire and Timothy P. Herbert named Chair and Chief Executive Officer
05 Febrero 2024 - 7:00AM
Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical
technology company focused on the development and commercialization
of innovative, minimally invasive solutions for patients with
obstructive sleep apnea (OSA), today announced the retirement of
Marilyn Carlson Nelson as Chair of its Board of Directors and the
appointment of Chief Executive Officer Timothy P. Herbert to the
additional role of Board Chair, to be effective at the conclusion
of the Company’s Annual Meeting of Stockholders scheduled to occur
on May 2, 2024.
“Marilyn has had a profound impact on our business
and our employees through her many years on the board,” said Tim
Herbert, President and Chief Executive Officer of Inspire Medical
Systems. “I want to personally thank Marilyn for her leadership and
mentoring not only myself but the entire team over many years. She
is an inspiration to the entire organization. Looking forward, it
is both humbling and exciting to accept the position of Board Chair
following the amazing path set by Marilyn. I am confident in our
ability to maintain the strong patient outcomes provided by Inspire
therapy and continue the growth in Inspire therapy adoption.”
Ms. Nelson joined the Board as Chair in 2018
following the passing of her husband and the original Chair of
Inspire’s Board, Glen D. Nelson, M.D. Mr. Herbert is the founder of
Inspire and has served as President and CEO since May of 2007.
Mr. Herbert's decades of expertise in the medical
device industry as well as his deep understanding of the business
that he founded make him uniquely qualified to effectively manage
the business, execute on our strategic priorities and lead the
Board. The Board has appointed Gary Ellis to the role of Lead
Independent Director. Mr. Ellis was appointed to the Inspire Board
in 2019 following an extensive career as Chief Financial Officer of
Medtronic and serves as the Chair of the Nominating and Corporate
Governance Committee.
About Inspire Medical Systems
Inspire is a medical technology company focused on
the development and commercialization of innovative, minimally
invasive solutions for patients with obstructive sleep apnea.
Inspire’s proprietary Inspire therapy is the first and only
FDA-approved neurostimulation technology that provides a safe and
effective treatment for moderate to severe obstructive sleep
apnea.
For additional information about Inspire, please
visit www.inspiresleep.com.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. All statements other than statements of historical facts are
forward-looking statements. Forward-looking statements involve
inherent risks and uncertainties, and important factors could cause
actual results to differ materially from those anticipated,
including the factors identified under the captions “Risk Factors”
and “Management's Discussion and Analysis of Financial Condition
and Results of Operations” in our Annual Report on Form 10-K for
the fiscal year ended December 31, 2022 filed with the SEC, and as
such factors may be updated from time to time in our other filings
with the SEC, which are accessible on the SEC’s website at
www.sec.gov and the Investors page of our website at
www.inspiresleep.com. Forward-looking statements speak only as of
the date they are made, and we undertake no obligation to update
them in light of new information or future events.
Investor and Media ContactEzgi YagciVice
President, Investor
Relationsezgiyagci@inspiresleep.com617-549-2443
Inspire Medical Systems (NYSE:INSP)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Inspire Medical Systems (NYSE:INSP)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024